Correlation between non-alcoholic fatty liver disease and metabolic parameters in persons with newly diagnosed type 2 diabetes mellitus

2024-8-27

Tissue inhibitor of metalloproteinase-3 expression affects clinicopathological features and prognosis of aflatoxin B1-related hepatocellular carcinoma

2024-8-27

Dynamics of glutamine synthetase expression in hepatic ischemia-reperfusion injury: Implications for therapeutic interventions

2024-8-27

Alpha-1 antitrypsin deficiency and Pi*Z allele as important co-factors in the development of liver fibrosis

2024-8-27

Intermittent fasting and the liver: Focus on the Ramadan model

2024-8-27

Gadoxetic acid-enhanced magnetic resonance imaging in the assessment of hepatic sinusoidal obstruction syndrome in a mouse model

2024-8-27

Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review

2024-8-27

Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?

2024-8-27

Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis

2024-8-22

<i>Rocahepevirus ratti</i>: An underrecognised cause of acute hepatitis

2024-8-22

Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis

2024-8-22

Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes

2024-8-22

Hepatoprotective effects of Xiaoyao San formula on hepatic steatosis and inflammation <i>via</i> regulating the sex hormones metabolism

2024-7-27

Interleukin-mediated therapies in liver diseases and comorbidity effects

2024-7-27

Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered

2024-7-27

Trends of autoimmune liver disease inpatient hospitalization and mortality from 2011 to 2017: A United States nationwide analysis

2024-7-27

Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years

2024-7-27

Immunoprophylaxis failure and vaccine response in infants born to mothers with chronic hepatitis B infection in Djibouti

2024-7-27

Roles of transforming growth factor-β signaling in liver disease

2024-7-27

Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction

2024-7-27

Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis

2024-7-27

Acute liver failure: A clinically severe syndrome characterized by intricate mechanisms

2024-7-26

Diagnostic and prognostic role of LINC01767 in hepatocellular carcinoma

2024-6-27

In-hospital outcomes in COVID-19 patients with non-alcoholic fatty liver disease by severity of obesity: Insights from national inpatient sample 2020

2024-6-27

Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both

2024-6-27

Hepatitis B cure: Current situation and prospects

2024-6-27

Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase

2024-6-27

Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature

2024-6-27

Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study

2024-6-27

From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology

2024-6-27

Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis

2024-6-19

Importance of the gut microbiota in the gut-liver axis in normal and liver disease

2024-6-19

Milestones to optimize of transjugular intrahepatic portosystemic shunt technique as a method for the treatment of portal hypertension complications

2024-6-19

Cold ischemia time in liver transplantation: An overview

2024-6-19

Ornithine aspartate effects on bacterial composition and metabolic pathways in a rat model of steatotic liver disease

2024-5-27

Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis

2024-5-27

Genetic screening of liver cancer: State of the art

2024-5-27

Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease

2024-5-27

Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective

2024-5-27

Quantifying the natural growth rate of hepatocellular carcinoma: A real-world retrospective study in southwestern China

2024-5-27

Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease

2024-5-27

Microbiota treatment of functional constipation: Current status and future prospects

2024-5-27

Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges

2024-5-27

Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?

2024-5-27

Outcomes of endoscopic submucosal dissection in cirrhotic patients: First American cohort

2024-5-27

Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease

2024-5-27

Current concepts in the management of non-cirrhotic non-malignant portal vein thrombosis

2024-5-27

Genetic diversity and occult hepatitis B infection in Africa: A comprehensive review

2024-5-27

Hepatic pseudotumor: A diagnostic challenge

2024-5-27

Characteristics of patients with Wilson disease in the United States: An insurance claims database study

2024-5-27